LX1001
LX1001-01
Phase 2 mab completed
Quick answer
LX1001 for Alzheimer Disease is a Phase 2 program (mab) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Alzheimer Disease
- Phase
- Phase 2
- Modality
- mab
- Status
- completed